| 1 |
27100185 | Association of Angiopoietin-2 and Ki-67 Expression with Vascular Density and Sunitinib Response in Metastatic Renal Cell Carcinoma. | 2016 |
3 |
| 2 |
24704536 | The role of angiopoietins as potential therapeutic targets in renal cell carcinoma. | 2014 Apr |
5 |
| 3 |
25100134 | Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential efficacy biomarkers of first-line sunitinib therapy for advanced renal cell carcinoma. | 2014 Oct |
1 |
| 4 |
23730410 | Evaluation of potentially predictive markers for anti-angiogenic therapy with sunitinib in recurrent ovarian cancer patients. | 2013 Jun |
1 |
| 5 |
21953673 | Sunitinib-induced changes in circulating endothelial cell-related proteins in patients with metastatic renal cell cancer. | 2012 Aug 15 |
3 |
| 6 |
21233403 | Specifically targeting angiopoietin-2 inhibits angiogenesis, Tie2-expressing monocyte infiltration, and tumor growth. | 2011 Mar 1 |
1 |
| 7 |
18316579 | Impact of angiogenesis inhibition by sunitinib on tumor distribution of temozolomide. | 2008 Mar 1 |
1 |